Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Strata Skin Sciences Inc (SSKN)
NASDAQ:SSKN
Holding SSKN?
Track your performance easily
Earnings Data
Report Date
Mar 25, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-0.4Last Year’s EPS
-0.42Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 13, 2018
|% Change Since: -13.13%
|Next Earnings Date:Aug 13, 2018
Earnings Call Sentiment|Neutral
The earnings call highlighted several positive developments, such as improved gross margins, increased patient appointments through DTC initiatives, growth of TheraClearX devices, and a favorable litigation outcome. However, challenges remain with slight declines in total revenue and domestic recurring billings, and the impact of a sales tax audit accrual. Despite these challenges, the company's strategic efforts and strengthened financial position are paving the way for potential growth and profitability.Company Guidance
During the third quarter earnings call for STRATA Skin Sciences, several key performance metrics were highlighted, showcasing the company's ongoing corporate turnaround. Revenue per XTRAC device grew by 2% year-over-year, a positive shift from the previous flat growth in the second quarter, and a notable improvement from the 10% decline observed in fiscal 2023. The gross margin increased to 60.3%, marking the third consecutive quarter of improvement, up from 56% in the second quarter of 2023. Non-GAAP operating expenses, excluding a one-time sales tax accrual of $1.8 million, decreased to $5.2 million from $5.6 million in Q3 2023. The company's Direct to Consumer initiatives led to over 1,900 new patient appointments in 2024, compared to only 8 in 2023. Additionally, STRATA's domestic installed base of XTRAC devices saw a slight decrease to 873 units, aligning with a strategy to eliminate underperforming units. Despite this, the third quarter's average revenue per XTRAC device was the highest since 2022. Other highlights included securing preauthorizations for over 2,000 acne patients for TheraClearX devices, and a favorable litigation outcome preventing a competitor from making misleading claims about their laser device. The quarter concluded with a total revenue of $8.8 million, a slight decline from $8.9 million in Q3 2023, and a cash position of $8.4 million, supporting the company's growth initiatives and strategic goals for 2024.Improvement in Gross Margin
Gross margin improved for the third consecutive quarter, reaching 60.3% in Q3 2024 compared to 56% in Q3 2023.
Significant Increase in New Patient Appointments
Year-to-date, over 1,900 new patient appointments were scheduled through Direct to Consumer efforts, a notable increase from just 8 in 2023.
TheraClearX Device Growth
The installed base of TheraClearX devices grew to 135 units at the end of Q3 2024, from 117 units at the end of Q2 2024.
Positive Litigation Outcome
A court order was obtained preventing a competitor from making false claims about their laser device compared to XTRAC excimer device.
Equity Raised to Strengthen Cash Position
In July 2024, $2.1 million was raised through equity, with strong participation from existing shareholders and insiders.
---
SSKN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SSKN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 13, 2024 | $3.35 | $3.10 | -7.46% |
| Aug 14, 2024 | $2.79 | $2.77 | -0.72% |
| May 15, 2024 | $4.20 | $3.82 | -9.05% |
| Mar 27, 2024 | $4.45 | $3.78 | -15.06% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Strata Skin Sciences Inc (SSKN) report earnings?
Strata Skin Sciences Inc (SSKN) is schdueled to report earning on Mar 25, 2025, TBA Not Confirmed.
What is Strata Skin Sciences Inc (SSKN) earnings time?
Strata Skin Sciences Inc (SSKN) earnings time is at Mar 25, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SSKN EPS forecast?
SSKN EPS forecast for the fiscal quarter 2024 (Q4) is -0.4.
---